Hou, H., Tsai, C., Lin, C., Chou, W., Kuo, Y., Liu, C., . . . Tien, H. (2018). Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome. Blood Cancer J.
Citação norma ChicagoHou, Hsin-An, et al. "Incorporation of Mutations in Five Genes in the Revised International Prognostic Scoring System Can Improve Risk Stratification in the Patients With Myelodysplastic Syndrome." Blood Cancer J 2018.
Citação norma MLAHou, Hsin-An, et al. "Incorporation of Mutations in Five Genes in the Revised International Prognostic Scoring System Can Improve Risk Stratification in the Patients With Myelodysplastic Syndrome." Blood Cancer J 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.